Cargando…
The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017)
INTRODUCTION: This study aimed to evaluate the performance of the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS) in estimating cancer incidence by comparing the results with the Beijing Cancer Registry (BCR), which is one of the highest-quality population-based cancer registrie...
Autores principales: | Tian, Hongrui, Liu, Weiping, Song, Yuqin, Mi, Lan, Liu, Zhen, Liu, Mengfei, Guo, Chuanhai, Liu, Fangfang, Liu, Ying, Pan, Yaqi, Zhu, Jun, He, Zhonghu, Ke, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855075/ https://www.ncbi.nlm.nih.gov/pubmed/35186368 http://dx.doi.org/10.46234/ccdcw2021.269 |
Ejemplares similares
-
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China
por: Tian, Hongrui, et al.
Publicado: (2021) -
Knowledge Graph: Applications in Tracing the Source of Large-Scale Outbreak — Beijing Municipality, China, 2020–2021
por: Shen, Ying, et al.
Publicado: (2023) -
Optimization of Population-Level Testing, Contact Tracing, and Isolation in Emerging COVID-19 Outbreaks: a Mathematical Modeling Study — Tonghua City and Beijing Municipality, China, 2021–2022
por: Wang, Zengmiao, et al.
Publicado: (2023) -
Estimating New Cases Among Athletes During the Winter Olympics Based on a Dynamic Model — Beijing, China, February 2022
por: Zhang, Zonghao, et al.
Publicado: (2022) -
Detection of SARS-CoV-2 Antibodies in Oral Fluid Using a Magnetic Particle-Based Chemiluminescence Immunoassay — Beijing Municipality, China, 2021
por: Mao, Naiying, et al.
Publicado: (2022)